Post-earnings recap
Reported
Wed, Jul 29, 2009
EPS actual
$2.44
EPS est.
$1.04
EPS surprise
+135.20%
1-day move
-1.35%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Sanofi's strong EPS performance indicates better-than-expected profitability, but the stock's decline of 1.35% suggests investor concerns about future revenue growth or market conditions. The lack of revenue data and guidance may have contributed to the cautious market reaction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.44 | N/A | +135.20% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a steady outlook despite market pressures. They emphasized the importance of their product portfolio.
Management highlighted strong performance in key product lines.
They noted ongoing challenges in the market but expressed confidence in their pipeline.